Datasets:
August Prendergast
August-P/
Intranasal-Insulin-PD
0
Downloads: 3
[c3efed]: / safety-and-preliminary-efficacy-of-intranasal-insulin-for-cognitive-impairment-in-parkinson-disease-and-multiple-system-atrophy-1 / PD-Table1.csv

Download this file

# Study No Pharmacy excluded IversusP Pre-Post Age Gender Etnicity Smoking Height (in) Weight BMI Disease Disease Duration SBP DBP HR Walk-Duration Walk-NoSteps AverStride (in) MOCA Glucose SBP DBP HR BMI 2 Walk-Duration 2 Walk-NoSteps 2 AverStrid (in) 2 Gait Speed 2 HnH PGI-I BDI MOCA 2 F#words A#words S#words FAS Pre-Post Glucose 2 MOCA 3 Walk-Duration 3 Walk-NoSteps 3 AverStrid (in) 3 Gait Speed 3 HnH 2 PGI-I 2 BDI 2 F#words 2 A#words 2 S#words 2 FAS 2
1 1 n/a excluded/screen failure Post
2 2 1-PD 0 Pre 79 1 w 0 69 176 26.02 PD 3 154 88 66 5.81 9 16 26 84 148 82 62 26.02 4.76 7 21 1.050420168 2.5 3 17 27 16 7 8 31 Post 73 24 5.45 9 16 0.917431193 2.5 3 13 6 4 10 20
3 3 2-PD 1 Pre 64 1 w 0 76.5 184 22.1 PD 9 129 83 70 3.72 7 21 30 89 129 83 70 22.1 3.9 7 21 1.282051282 2.5 3 3 30 15 16 15 46 Post 83 29 4.08 7 21 1.225490196 2.5 3 3 15 17 16 48
4 4 3-PD 0 Pre 53 2 w 0 67 155 24.3 PD 5 113 69 70 3.84 8 18 28 98 113 69 70 24.3 4.4 8 18 1.136363636 2.5 3 15 29 11 11 12 34 Post 98 30 4.55 8 18 1.098901099 2.5 3 13 11 8 9 28
5 5 4-PD 1 Pre 71 1 a 0 68 157 23.9 PD 17 114 74 62 3.37 7 21 26 83 114 64 72 23.9 3.19 6 24 1.567398119 2.5 3 6 28 16 12 9 37 Post 72 28 3.73 7 21 1.340482574 2.5 3 3 16 16 17 49
6 6 5-PD 0 Pre 56 2 w 0 60 140 27.3 PD 5 112 75 80 4.67 8 18 28 86 112 73 78 27.3 4.65 8 18 1.075268817 2.5 3 14 30 11 12 11 34 Post 112 29 5.13 8 18 0.974658869 2.5 3 20 10 11 12 33
7 7 6-PD 0 Pre 66 2 w 0 63 123 21.8 PD 7 139 83 66 4.11 6 24 25 106 139 83 66 21.8 4.23 6 24 1.182033097 2 3 2 27 15 10 10 35 Post 77 30 4.08 6 24 1.225490196 2.5 3 0 10 7 14 31
8 8 7-PD 1 Pre 66 1 w 0 61.1 197 27.5 PD 6 114 69 73 3.66 8 18 28 100 114 69 73 27.5 3.66 8 18 1.366120219 2 3 4 27 10 8 16 34 Post 100 28 3.7 6 24 1.351351351 1 3 2 12 12 16 40
9 9 8-PD 1 Pre 64 2 w 0 65 115 18.8 PD 4 128 70 72 3.68 6 24 28 88 128 70 72 18.8 4.4 7 21 1.136363636 2.5 3 6 30 12 8 14 34 Post 79 28 3.4 7 21 1.470588235 1 3 4 13 9 14 36
10 10 9-PD 0 Pre 56 1 w 0 75 275 34.4 PD 3 132 84 108 3.78 6 24 29 103 135 81 102 34.4 3.7 7 21 1.351351351 2 3 17 25 8 8 13 29 Post 97 29 3.6 7 21 1.388888889 2.5 3 20 10 9 12 31
11 11 10-PD 1 Pre 65 2 w 0 68 125 19 PD 4 147 98 90 6.03 11 13 28 79 124 80 75 19 4.89 9 16 1.022494888 4 3 20 29 14 15 13 42 Post 77 30 6.16 10 14 0.811688312 2.5 4 26 11 10 10 31
12 12 11-PD 1 Pre 60 1 w 0 77 229 28.2 PD 2 111 67 59 3.01 5.5 26 28 90 111 67 59 28.2 2.83 5 29 1.766784452 2.5 3 6 28 9 10 11 30 Post 95 27 6 24 mv 1.5 3 5 8 8 13 29
13 13 12-PD 0 Pre 63 1 w 0 68 255 38.8 PD 8 138 87 67 5.11 7 21 24 81 138 87 67 38.8 4.38 6 24 1.141552511 3 3 16 23 9 11 14 34 Post 63 27 4.64 8 18 1.077586207 2 2 11 15 12 15 42
14 14 13-PD Excluded Adverse event 1 Pre
15 15 14-PD 1 Pre 66 1 w 0 68 185 28.1 PD 10 mv mv mv 4.2 8 18 27 95 mv mv mv 28.1 4.43 8 18 1.128668172 2.5 3 7 28 16 9 18 43 Post 85 27 4.25 8 18 1.176470588 2.5 3 11 18 12 19 49
16 16 1-MSA 1 Pre 50 1 w 0 MV mv mv MSA 2 104 68 59 3.11 5 29 27 97 104 68 59 mv 2.75 5 29 1.818181818 2.5 3 11 30 14 13 17 44 Post 94 27 2.99 5 29 1.672240803 2.5 3 12 16 12 18 46